
Oncology
Moving PARP Inhibition Upfront: Why the Phase 3 TALAPRO-3 Trial Rewrites Treatment for HRR-Deficient mCSPC
From Late to Early Intervention: Advanced Prostate Cancer Treatment.
Rayan Salih · 9 min read
The archive
293 stories, newest first — page 4 of 13.

Oncology
From Late to Early Intervention: Advanced Prostate Cancer Treatment.
Rayan Salih · 9 min read

Cardiology
In the rapidly evolving landscape of neurological research, precision medicine requires clinicians and clinical researchers to scrutinize established
Rayan Salih · 9 min read

Oncology
The therapeutic landscape for oncogene-addicted non-small cell lung cancer (NSCLC) has shifted dramatically over the past decade.
Rayan Salih · 8 min read

Cardiology
Advanced heart failure is not defined by one test or one number.
Dr. Abu Bakar · 7 min read

Innovation & Devices
The arrival of a Neuralink brain-computer interface into a real-world clinical setting marks a turning point.
Dr. Abu Bakar · 6 min read

Cardiology
Abbott’s Navitor transcatheter aortic valve implantation (TAVI) system is drawing new attention after one year outcome data suggested
Dr. Abu Bakar · 8 min read

Clinical Briefs
A baby’s safest sleep can depend on just a few simple choices, yet for many new parents, those
Dr. Abu Bakar · 7 min read

Oncology
For years, oncology providers have recognized that metastatic colorectal cancer (mCRC) is not a monolithic disease.
Rayan Salih · 9 min read

Oncology
The landscape of advanced oncology is undergoing an unprecedented structural transition.
Rayan Salih · 9 min read

Oncology
For generations, clinical practice models and medical education have operated under a foundational axiom: cancer is fundamentally a
Rayan Salih · 10 min read

Neurology
Schizophrenia has long been recognized as one of the most complex, chronic, and debilitating challenges in modern psychiatry….
Rayan Salih · 11 min read

Oncology
For decades, clinicians treating metastatic pancreatic ductal adenocarcinoma (mPDAC) have operated under a somber reality.
Rayan Salih · 8 min read

Cardiology
GLP-1 agonist drugs (like semaglutide or liraglutide) have become common choices for treating obesity and type 2 diabetes….
Dr. Abu Bakar · 7 min read

Innovation & Devices
Becton, Dickinson and Company (BD) has just launched the ELYRA thulium fiber laser system for kidney stone treatment….
Dr. Abu Bakar · 8 min read

Cardiology
Many people with chest pain leave the hospital after an angiogram only to hear that their major coronary
Dr. Abu Bakar · 8 min read

Women's Health
Preeclampsia risk is one of the most important safety questions in pregnancy care.
Dr. Abu Bakar · 9 min read

Innovation & Devices
Intuitive’s latest wave of updates for the da Vinci 5 surgical system focuses on two practical areas hospitals
Rayan Salih · 7 min read

Neurology
For patients with uncontrolled epilepsy, the threat of an unexpected seizure is a constant source of profound anxiety….
Rayan Salih · 9 min read

Neurology
For decades, the clinical narrative surrounding migraine and stroke risk has been clear-cut, specific, and highly selective.
Rayan Salih · 8 min read

Health Policy
Pharmacist-led discharge care is an increasingly visible approach to easing the risky period right after a patient leaves
Rayan Salih · 7 min read

Endocrinology & Metabolism
The biopharmaceutical industry is undergoing a structural realignment that will directly shape clinical practice, formulary designs, and treatment
Rayan Salih · 7 min read

Infectious Disease
The combination therapy involving colistin-meropenem has emerged as a possible treatment choice for severe infections resistant to antibiotics….
Dr. Abu Bakar · 8 min read

Mental & Behavioral Health
The GLP-1 receptor agonist is an agent used for the management of type 2 diabetes mellitus and body
Dr. Abu Bakar · 7 min read

Cardiology
Tricuspid regurgitation is a condition commonly found in people who have been suffering from atrial fibrillation for quite
Dr. Abu Bakar · 8 min read